Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-005072
Filing Date
2023-11-30
Accepted
2023-11-30 13:36:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2965
  Complete submission text file 0001959173-23-005072.txt   4321
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38276 | Film No.: 231454992
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON ST., SUITE 3310 PRUDENTIAL TOWER C/O AJU IB INVESTMENT BOSTON MA 02199
Business Address
Sullivan Timothy Eugene (Reporting) CIK: 0001707000 (see all company filings)

Type: 144